Post-initiation treatment of rats with indole-3-carbinol or beta-naphthoflavone does not suppress 7, 12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis.
Post-initiation treatment of rats with indole-3-carbinol or beta-naphthoflavone does not suppress 7, 12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis.
复制标题
用吲哚-3-甲醇或β-萘黄酮对大鼠进行启动后治疗不会抑制7, 12-二甲基苯并[a]蒽诱导的乳腺癌发生。
DOI:
10.1016/s0304-3835(00)00594-2
复制
发表时间:
2000
期刊:
影响因子:
9.7
通讯作者:
Bliss,RL
中科院分区:
文献类型:
--
作者:
Malejka-Giganti,D;Niehans,GA;Reichert,MA;Bliss,RL
Indole-3-carbinol (I3C) and β-naphthoflavone (β-NF), blocking agents of 7,12-dimethylbenz[a]anthracene (DMBA)-initiated mammary gland carcinogenesis, were examined as potential post-initiation suppressing agents. Treatment of female Sprague–Dawley rats with I3C (250 mg/kg body weight (b.w.)), β-NF (20 mg/kg b.w.) or the vehicle ethanol:corn oil (2:3) (2.5 ml/kg b.w.), three times weekly by gavage, started 3 weeks after the initiation with one oral dose of DMBA (20 mg/rat at 7 weeks of age) and continued for up to 12 weeks. I3C- or β-NF- or vehicle-treated groups did not differ significantly in the overall outcome of mammary tumorigenesis including cumulative mammary tumor incidences and multiplicities, latent periods and number and weight of mammary tumors per tumor-bearing rat for malignant, benign and/or malignant + benign tumors. A tendency of the I3C-treated rats to develop fewer mammary adenocarcinomas with a greater average weight per tumor per rat (2.32±1.50 g) than in the β-NF- (1.52±1.58 g) or vehicle- (1.55±1.53 g) treated groups suggests an effect, yet to be confirmed, of I3C on tumor development and growth. A 12-week treatment with I3C or β-NF significantly increased the P450-dependent activities of ethoxy-, methoxy-, benzyloxy- and pentoxy-(with I3C only) resorufin O-dealkylase in hepatic microsomes indicating induction of several P450s. The alterations in the P450 complement may affect endogenous estrogen metabolism and mammary gland and tumor characteristics at the molecular level, e.g. estrogen receptor status and/or proliferative activity, which require further studies.
登录
查看更多内容
影响因子:
13.5
作者:
S. Safe
通讯作者:
S. Safe
影响因子:
3.5
作者:
Di F. Tenchio
通讯作者:
Di F. Tenchio
影响因子:
5.8
作者:
Ritter,CL;Malejka-Giganti,D
通讯作者:
Malejka-Giganti,D
影响因子:
9.7
作者:
H. Mori;S. Sugie;W. Rahman;N. Suzui
通讯作者:
N. Suzui
DOI:
10.1093/jnci/86.2.126
发表时间:
1994-01-19
期刊:
JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子:
--
作者:
TIWARI, RK;GUO, L;OSBORNE, MP
通讯作者:
OSBORNE, MP